MedTrace Logo

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

NCT01392222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2017-06-21

No results posted yet for this study

Summary

The purpose of this study is to understand more about why some patients choose to have surgery to treat their papillary microcarcinoma (PMC) and others choose to have their papillary microcarcinoma (PMC) regularly watched by their doctor to see if and when they may need surgery (referred to as "active surveillance"). The investigators also hope learn more about what patients and their family members worry about or feel they will gain from surgery or active surveillance.

Conditions

Interventions

BEHAVIORAL

Focus groups

The focus groups will cover the following issues * Perceptions of thyroid cancer and disease status * Sources of information used in papillary microcarcinoma treatment decision-making * Treatment decision-making processes and influential factors * Perceived barriers to active surveillance to treat papillary microcarcinoma (for the immediate surgery sub-sample) * Perceived facilitators to active surveillance to treat papillary microcarcinoma (for the non-immediate surgery sub-sample) * Views about how to improve acceptability of active surveillance as a disease management option

BEHAVIORAL

Focus groups

The focus groups will cover the following issues: * Perceptions of thyroid cancer and disease status * Sources of information used in papillary microcarcinoma treatment decision-making * Treatment decision-making processes and influential factors * Perceived barriers to active surveillance to treat papillary microcarcinoma (for the immediate surgery sub-sample) * Perceived facilitators to active surveillance to treat papillary microcarcinoma (for the non-immediate surgery sub-sample) * Views about how to improve acceptability of active surveillance as a disease management option

Sponsors & Collaborators

Principal Investigators

  • Smita Banerjee, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392222 on ClinicalTrials.gov